BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23087319)

  • 1. External support in preventing vein graft failure.
    Hu J; Wan S
    Asian Cardiovasc Thorac Ann; 2012 Oct; 20(5):615-22. PubMed ID: 23087319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term reduction of medial and intimal thickening in porcine saphenous vein grafts with a polyglactin biodegradable external sheath.
    Vijayan V; Shukla N; Johnson JL; Gadsdon P; Angelini GD; Smith FC; Baird R; Jeremy JY
    J Vasc Surg; 2004 Nov; 40(5):1011-9. PubMed ID: 15557918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of saphenous vein graft failure: a brief overview of interventions.
    Shukla N; Jeremy JY
    Curr Opin Pharmacol; 2012 Apr; 12(2):114-20. PubMed ID: 22321569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions.
    Harskamp RE; Lopes RD; Baisden CE; de Winter RJ; Alexander JH
    Ann Surg; 2013 May; 257(5):824-33. PubMed ID: 23574989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy and coronary artery bypass grafting: current perspectives.
    George SJ; Channon KM; Baker AH
    Curr Opin Mol Ther; 2006 Aug; 8(4):288-94. PubMed ID: 16955691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the biology of saphenous vein grafts fitted with external synthetic sheaths and stents.
    Jeremy JY; Gadsdon P; Shukla N; Vijayan V; Wyatt M; Newby AC; Angelini GD
    Biomaterials; 2007 Feb; 28(6):895-908. PubMed ID: 17113144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing treatment failures in coronary artery disease: what can we learn from the biology of in-stent restenosis, vein graft failure, and internal thoracic arteries?
    Spadaccio C; Antoniades C; Nenna A; Chung C; Will R; Chello M; Gaudino MFL
    Cardiovasc Res; 2020 Mar; 116(3):505-519. PubMed ID: 31397850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards the treatment of saphenous vein bypass graft failure--a perspective of the Bristol Heart Institute.
    Angelini GD; Jeremy JY
    Biorheology; 2002; 39(3-4):491-9. PubMed ID: 12122271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond embolic protection for saphenous vein graft disease.
    Satler LF
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):641-2. PubMed ID: 18949778
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term performance of an external stent for saphenous vein grafts: the VEST IV trial.
    Taggart DP; Webb CM; Desouza A; Yadav R; Channon KM; De Robertis F; Di Mario C
    J Cardiothorac Surg; 2018 Nov; 13(1):117. PubMed ID: 30453984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does a 'no-touch' technique result in better vein patency?
    Sepehripour AH; Jarral OA; Shipolini AR; McCormack DJ
    Interact Cardiovasc Thorac Surg; 2011 Dec; 13(6):626-30. PubMed ID: 21908888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Coronary artery bypass : Vein graft lesion].
    Maehara A; Ishiwata S; Momomura S; Yamaguchi T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():600-4. PubMed ID: 12735038
    [No Abstract]   [Full Text] [Related]  

  • 13. Bone morphogenic protein-4: a potential novel target for preventing vein graft failure in coronary revascularization.
    Hu J; Zhao JJ
    Med Hypotheses; 2013 Dec; 81(6):1025-8. PubMed ID: 24119764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of neointimal hyperplasia associated with modified stretch expanded polytetrafluoroethylene hemodialysis grafts (Gore) in an experimental preclinical study in swine.
    Gessaroli M; Bombardi C; Giunti M; Bacci ML
    J Vasc Surg; 2012 Jan; 55(1):192-202. PubMed ID: 21944911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vascular biology of coronary bypass grafts. Literature review].
    Barandon L; Kindo M; Perrault LP; Hebert Y; Cartier R; Bouchard D; Demers P; Pagé P; Carrier M; Pellerin M
    Arch Mal Coeur Vaiss; 2004 Dec; 97(12):1206-15. PubMed ID: 15669362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External Stents for Vein Grafts in Coronary Artery Bypass Grafting: Targeting Intimal Hyperplasia.
    Weltert LP; Wolf LG; Garufi L; Scaffa R; Salica A; Ricci A; Irace FG; Fusca S; D'Aleo S; Chirichilli I; Bellisario A; de Paulis R
    Surg Technol Int; 2020 May; 35():197-201. PubMed ID: 32120449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term effects of double-layer autologous vein graft on restraint of excessive distension and alleviation of neointimal hyperplasia in a porcine saphenous vein graft model.
    Ji Q; Mei Y; Wang X; Feng J; Cai J; Sun Y; Dewei W; Wang C; Chi L
    Heart Vessels; 2011 Mar; 26(2):190-5. PubMed ID: 21188389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the Prairie "Real World" Stent Registry.
    Goswami NJ; Gaffigan M; Berrio G; Plessa AL; Pfeiffer AM; Markwell SJ; Mishkel GJ
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):93-100. PubMed ID: 19787803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saphenous vein graft intervention: a review.
    Hindnavis V; Cho SH; Goldberg S
    J Invasive Cardiol; 2012 Feb; 24(2):64-71. PubMed ID: 22294536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy to prevent occlusion of venous bypass grafts.
    Bhardwaj S; Roy H; Ylä-Herttuala S
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):641-52. PubMed ID: 18510482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.